Novick A C, Ziegelbaum M, Vidt D G, Gifford R W, Pohl M A, Goormastic M
JAMA. 1987;257(4):498-501.
We reviewed our experience with surgical revascularization (SR) for renal artery disease (RAD) in 361 patients from 1975 through 1984 to illustrate the evolving role of SR in the management of these patients. The time intervals selected for comparison were 1975 through 1980 (n = 174) and 1981 through 1984 (n = 187). Since 1981, in patients with atherosclerosis, SR has been done more often in elderly patients (30% vs 10.4%), in patients with generalized atherosclerosis (87% vs 73%), and for the sole purpose of preserving renal function (36% vs 14%). Since 1981, fewer patients with atherosclerosis have undergone SR solely to treat renovascular hypertension (26% vs 41%). Since 1981, in patients with fibrous dysplasia, SR has been done in more patients with branch renal artery disease (70% vs 28%). These trends in the performance of SR have been due to the advent of percutaneous transluminal angioplasty as effective therapy for certain patients, improved results of SR in elderly patients with atherosclerosis, an enhanced appreciation of advanced atherosclerotic RAD as a correctable cause of renal failure, and the development of more effective techniques for SR in patients with severe aortic atherosclerosis and branch RAD. The overall clinical results of SR remain excellent in properly selected patients with RAD.
我们回顾了1975年至1984年间361例肾动脉疾病(RAD)患者接受外科血管重建术(SR)的经验,以说明SR在这些患者治疗中的作用演变。选择用于比较的时间间隔为1975年至1980年(n = 174)和1981年至1984年(n = 187)。自1981年以来,对于动脉粥样硬化患者,SR在老年患者中实施得更为频繁(30%对10.4%),在患有全身性动脉粥样硬化的患者中更为频繁(87%对73%),并且仅为了保留肾功能这一目的(36%对14%)。自1981年以来,仅为治疗肾血管性高血压而接受SR的动脉粥样硬化患者减少了(26%对41%)。自1981年以来,对于纤维肌发育不良患者,SR在更多患有肾动脉分支疾病的患者中实施(70%对28%)。SR实施情况的这些趋势归因于经皮腔内血管成形术作为某些患者的有效治疗方法的出现、老年动脉粥样硬化患者SR结果的改善、对晚期动脉粥样硬化性RAD作为肾衰竭可纠正病因的认识增强,以及针对严重主动脉粥样硬化和肾动脉分支RAD患者开发出更有效的SR技术。在适当选择的RAD患者中,SR的总体临床结果仍然非常出色。